Send feedback

TYK2 p.Ile684Ser

c.2051T>G · rs12720356 · VCV259043

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 8 submitters
AlphaMissense
likely pathogenic
0.5863 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 9.37%, nfe) — too common for a highly-penetrant pathogenic allele
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
immunodeficiency 35

Computational evidence

Protein change
AlphaMissense0.5863likely pathogenic
REVEL0.343indeterminate
SaProtLLR -11.52damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call.
Splicing
SpliceAIΔ0.86acceptor gain · deltas
PangolinΔ0.27gain · loss 0.09 · agrees with SpliceAI · independent
Constraint at this position
ConservationphyloP 9.1GERP 0.41, phastCons 1
Regional constrainto/e 0.86unconstrained · MANE · 28 kb · p 6.7e-09 · regional, not allelic
Overall
CADD34.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 9.37% European (non-Finnish) · 110,559/1,179,728 alleles
Filtering AF 9.33% ClinGen BA1/BS1 input FAF95, joint · FAF99 9.31%
Overall 7.97% 128,313/1,610,644 alleles · common
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 10% 10
European (non-Finnish)grpmax 9.37% 11
Finnishnot grpmax-eligible 8.33% 12
Remaining individualsnot grpmax-eligible 7.67% 13
Middle Eastern 5.81% 17
Amishnot grpmax-eligible 5.04% 20
Admixed American 4.26% 23
African / African-American 1.41% 71
South Asian 0.989% 101
East Asian 0.0156% 6,409

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
TYK2
Protein
p.Ile684Ser
Coding
c.2051T>G
MANE Select
NM_003331
dbSNP
rs12720356
Type
single nucleotide variant
Location
chr19:10359299 (GRCh38)
Gene constraint
LOEUF 0.626 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 82.69 · 52 PDB
Residue 684
a UniProt-annotated variant site (in); the protein kinase 1 domain; a β-strand
Full TYK2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

immunodeficiency 35 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Susceptibility to infection due to TYK2 deficiency (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tyk2-p-ile684ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown